These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 9920535)

  • 1. A simplified empirical approach to evaluate the dissociation constant of a full agonist by the irreversible receptor inactivation method.
    Calderone V; Martinotti E
    J Pharmacol Toxicol Methods; 1998 Jul; 40(1):57-62. PubMed ID: 9920535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Furchgott's method to determine agonist-dependent A1-adenosine receptor reserve in guinea-pig atrium.
    Morey TE; Belardinelli L; Dennis DM
    Br J Pharmacol; 1998 Apr; 123(7):1425-33. PubMed ID: 9579739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic activity and EC50: the simplest tools for the evaluation of the dissociation constant of a partial agonist.
    Calderone V; Martinotti E
    J Pharmacol Toxicol Methods; 1998 Nov; 40(4):207-10. PubMed ID: 10465155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation.
    Black JW; Leff P; Shankley NP; Wood J
    Br J Pharmacol; 1985 Feb; 84(2):561-71. PubMed ID: 3978322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of agonist dissociation constants in isolated vasculature: equivalence of estimates obtained by the method of partial irreversible receptor inactivation and a novel application of the operational model of pharmacological agonism.
    Christ GJ
    Life Sci; 1990; 47(20):1867-74. PubMed ID: 2175378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of the functional dissociation constant of a partial agonist by comparison with a higher efficacy agonist.
    Freeman KA; Tallarida RJ
    J Pharmacol Methods; 1991 Mar; 25(1):11-8. PubMed ID: 1674291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Do pharmacological methods for the quantification of agonists work when the ternary complex mechanism operates?
    Leff P; Harper D
    J Theor Biol; 1989 Oct; 140(3):381-97. PubMed ID: 2515395
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New methods for determining dissociation constants of agonist-receptor complexes.
    Venter DP
    Eur J Pharmacol; 1996 May; 303(3):235-46. PubMed ID: 8813575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental and theoretical comparisons between the classical Schild analysis and a new alternative method to evaluate the pA2 of competitive antagonists.
    Calderone V; Baragatti B; Breschi MC; Martinotti E
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Nov; 360(5):477-87. PubMed ID: 10598787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimation of agonist affinity, using the slope of the concentration-effect curve: comment on the method of Calderone and Martinotti.
    Van der Graaf PH
    J Pharmacol Toxicol Methods; 1998 Nov; 40(4):241-3. PubMed ID: 10465160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation constants and relative efficacies of agonists acting on alpha adrenergic receptors in rabbit aorta.
    Besse JC; Furchgott RF
    J Pharmacol Exp Ther; 1976 Apr; 197(1):66-78. PubMed ID: 4613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new method for estimation of agonist dissociation constants (KA): directly fitting the postinactivation concentration-response curve to a nested hyperbolic equation.
    James MK; Morgan PH; Leighton HJ
    J Pharmacol Exp Ther; 1989 Apr; 249(1):61-9. PubMed ID: 2540322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantifying biological activity in chemical terms: a pharmacology primer to describe drug effect.
    Kenakin T
    ACS Chem Biol; 2009 Apr; 4(4):249-60. PubMed ID: 19193052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved models for pharmacological null experiments: calculation of drug efficacy at recombinant D1A dopamine receptors stably expressed in clonal cell lines.
    Mak CK; Avalos M; Randall PK; Kwan SW; Abell CW; Neumeyer JL; Whisennand R; Wilcox RE
    Neuropharmacology; 1996 May; 35(5):549-70. PubMed ID: 8887963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of allosterism in functional assays.
    Ehlert FJ
    J Pharmacol Exp Ther; 2005 Nov; 315(2):740-54. PubMed ID: 16046613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A three-state receptor model of agonist action.
    Leff P; Scaramellini C; Law C; McKechnie K
    Trends Pharmacol Sci; 1997 Oct; 18(10):355-62. PubMed ID: 9357320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comments on "Isobolographic analysis for combinations of a full and partial agonist: curved isoboles".
    Lorenzo JI; Sánchez-Marín P
    J Pharmacol Exp Ther; 2006 Jan; 316(1):476-8; author reply 479. PubMed ID: 16371451
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of the operational model of agonism to establish conditions when functional antagonism may be used to estimate agonist dissociation constants.
    Leff P; Martin GR; Morse JM
    Br J Pharmacol; 1985 Jul; 85(3):655-63. PubMed ID: 4027483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Quantitative parameters of drug-receptor interactions and receptor reserves. I. Models I-3-R and I-3-S].
    Wenke M; Lincová D; Foglar R
    Sb Lek; 1991 May; 93(3-4):65-77. PubMed ID: 1853140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the reliability of affinity and efficacy estimates obtained by direct operational model fitting of agonist concentration-effect curves following irreversible receptor inactivation.
    Van der Graaf PH; Danhof M
    J Pharmacol Toxicol Methods; 1997 Oct; 38(2):81-5. PubMed ID: 9403778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.